Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer - Related Studies

Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

This study has been completed.

Study NCT00004232. Last updated on November 16, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Graft Versus Host Disease
		Leukemia
		Lymphoma
		Myelodysplastic Syndromes
		Precancerous/Nonmalignant Condition

2	Additional conditions recognized in this trial
		Graft vs Host Disease
		Lymphoma, Large-Cell, Immunoblastic
		Lymphoma, Non-Hodgkin
		Multiple Myeloma
		Myeloproliferative Disorders
		Neoplasms, Plasma Cell
		Precancerous Conditions
		Preleukemia
		Syndrome

3	More general conditions related to this trial
		Blood Protein Disorders
		Bone Marrow Diseases
		Cardiovascular Diseases
		Disease
		Hematologic Diseases
		Hemorrhagic Disorders
		Hemostatic Disorders
		Immune System Diseases
		Immunoproliferative Disorders
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type
		Paraproteinemias
		Pathologic Processes
		Vascular Diseases

4	Interventions listed in this trial
		cyclosporine
		filgrastim
		methylprednisolone
		prednisone

5	Additional drug interventions recognized in this trial
		Cyclosporins
		Methylprednisolone acetate
		Methylprednisolone Hemisuccinate
		Prednisolone
		Prednisolone acetate

6	More general drug interventions related to this trial
		Anti-Infective Agents
		Anti-Inflammatory Agents
		Antiemetics
		Antifungal Agents
		Antineoplastic Agents
		Antineoplastic Agents, Hormonal
		Antirheumatic Agents
		Autonomic Agents
		Central Nervous System Agents
		Dermatologic Agents
		Enzyme Inhibitors
		Gastrointestinal Agents
		Glucocorticoids
		Hormones
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Neuroprotective Agents
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Protective Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		Robert H. Lurie Cancer Center
		National Cancer Institute (NCI)